Apolipoprotein B100 knock-down by AAV-delivered shRNA lowers cholesterol in mice

被引：0
|
作者：
Koornneef, A. [1 ]
Maczuga, P. [1 ]
van Logtenstein, R. [1 ]
Borel, F. [1 ]
Blits, B. [1 ]
Ritsema, T. [1 ]
van Deventer, S. [2 ]
Petry, H. [1 ]
Konstantinova, P. [1 ]
机构：
[1] AMT, NL-1105 BA Amsterdam, Netherlands
[2] LUMC, NL-2333 ZA Leiden, Netherlands
来源：
HUMAN GENE THERAPY | 2010年 / 21卷 / 10期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：1393 / 1393
页数：1
相关论文
共 44 条
  • [1] Apolipoprotein B Knockdown by AAV-delivered shRNA Lowers Plasma Cholesterol in Mice
    Koornneef, Annemart
    Maczuga, Piotr
    van Logtenstein, Richard
    Borel, Florie
    Blits, Bas
    Ritsema, Tita
    van Deventer, Sander
    Petry, Harald
    Konstantinova, Pavlina
    MOLECULAR THERAPY, 2011, 19 (04) : 731 - 740
  • [2] Apolipoprotein B Knock-Down by Chitosan/ApoB-siRNA Nanoparticles Lowers Plasma Cholesterol in Atherosclerosis Mouse Model
    Jean, Myriam
    Derbali, Rabeb
    Dejesus, Diogo
    Jeandupeux, Dominique
    Merzouki, Abderrazzak
    Buschmann, Michael D.
    MOLECULAR THERAPY, 2014, 22 : S143 - S143
  • [3] An apolipoprotein B100 mimotope prevents obesity in mice
    Kim, Hyo Joon
    Lee, Hee Jong
    Choi, Jung Soon
    Han, Jemin
    Kim, Ji Young
    Na, Hyun Kyun
    Joung, Hae-Jung
    Kim, Young Sik
    Binas, Bert
    CLINICAL SCIENCE, 2016, 130 (02) : 105 - 116
  • [4] Systemic shRNA mediated knock-down of S100A4 in colorectal cancer xenografted mice reduces metastasis formation
    Dahlmann, Mathias
    Sack, Ulrike
    Herrmann, Pia
    Lemm, Margit
    Fichtner, Iduna
    Schlag, Peter M.
    Stein, Ulrike
    ONCOTARGET, 2012, 3 (08) : 783 - 797
  • [5] Susceptibility to atherosclerosis in mice expressing exclusively apolipoprotein B48 or apolipoprotein B100
    Veniant, MM
    Pierotti, V
    Newland, D
    Cham, CM
    Sanan, DA
    Walzem, RL
    Young, SG
    JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (01): : 180 - 188
  • [6] Phenotypic analysis of mice expressing exclusively apolipoprotein B48 or apolipoprotein B100
    Farese, RV
    Veniant, MM
    Cham, CM
    Flynn, LM
    Pierotti, V
    Loring, JF
    Traber, M
    Ruland, S
    Stokowski, RS
    Huszar, D
    Young, SG
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (13) : 6393 - 6398
  • [7] Endogenous cholesterol synthesis determines the rate of VLDL2 apolipoprotein B100 secretion and not VLDL1 apolipoprotein B100 secretion in humans
    Prinsen, B
    Romijn, JA
    Bisschop, P
    de Barse, M
    Sauerwein, H
    Rabelink, T
    de Sain-van der Velden, M
    CIRCULATION, 2002, 106 (19) : 253 - 253
  • [8] Lentiviral shRNA knock-down of Macrophage inflammatory protein-1γ ameliorates experimentally induced osteoarthritis in mice
    Hsieh, Jeng-Long
    Shen, Po-Chuan
    Shiau, Ai-Li
    Wu, Chao-Liang
    HUMAN GENE THERAPY, 2012, 23 (10) : A131 - A131
  • [9] EXPRESSION OF HUMAN APOLIPOPROTEIN B100 IN TRANSGENIC MICE - EDITING OF HUMAN APOLIPOPROTEIN-B100 MESSENGER-RNA
    CHIESA, GL
    JOHNSON, DF
    YAO, ZM
    INNERARITY, TL
    MAHLEY, RW
    YOUNG, SG
    HAMMER, RH
    HOBBS, HH
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1993, 268 (32) : 23747 - 23750
  • [10] TOTAL CHOLESTEROL TO APOLIPOPROTEIN B100 RATIO IN ADVANCED STABLE ANGINA PATIENTS TREATED WITH STATINS
    Burchardt, P.
    Zuchowski, B.
    Palasz, A.
    Zurawski, J.
    Wysocki, H.
    ATHEROSCLEROSIS SUPPLEMENTS, 2011, 12 (01) : 25 - 25
12345